COLCOT-T2D
The Montreal Heart Institute is currently conducting a large clinical trial, COLCOT-T2D, to determine whether an anti-inflammatory drug (colchicine) and an anti-platelet drug (aspirin), in combination or alone, can prevent cardiovascular events in patients with type 2 diabetes who have never suffered a cardiovascular event.
Contact us : www.colcot-t2d.org or 1-877-587-3389
Read more
BURNOUT
Factors associated with BURNOUT in Quebec health care workers during the COVID-19 pandemic: An observational study
Dr. Judith Brouillette, psychiatrist at the Montreal Heart Institute (MHI), has undertaken, since May 14, 2020, a study on burnout factors among health professionals and workers.
The study is focusing on resilience, social support, workload, perceived organizational support, access to simulation techniques and mental health resources. The study is also testing whether the change in the stress hormone (cortisol) pre/post-pandemic, is associated with psychological distress during the pandemic.
Dr. Brouillette realizes this project together with 3 co-researchers (Dr. Jean-Claude Tardif, leader in per-pandemic clinical research project, Marie-France Marin, specialized in psychology and biological-cortisol measurements, and Stéphane Guay, director of the Trauma Studies Center). She also relies on the collaboration of researchers from different disciplines including nursing, positive and organizational psychology, neuropsychiatry, emergency and medicine from centers dedicated to COVID-19.
The study will be carried out in two phases (June 2020 and March 2021) and will require to:
- Complete an online questionnaire of about twenty minutes, and
- Provide before June 12, 2020 a hair sample that will measure the level of cortisol (stress hormone) pre- and post-pandemic (optional).
The results will lead to the development of more targeted interventions to preserve the psychologic health of health workers and professionals.
To ensure the success of the study, 300 participants must be recruited between May 21 at noon and June 5, 2020. The registration process will be done on the secure site of the Montreal Clinical Trials Coordination Center (MHICC) affiliated with the MHI. For information or to register, visit the following address: https://burnout.mhicc.org/
This study will be carried out with financial support from Quebec Ministry of Economy and Innovation and the Montreal Heart Institute Foundation.
Principal investigator and research team
Judith Brouillette, PhD MDPsychiatrist, assistant clinical professor and researcher
Head of the Department of Psychiatry - Montreal Heart Institute
Affiliated with the University of Montreal
judith.brouillette@icm-mhi.org
CONTACT : projet.burnout@icm-mhi.org